(Vibostolimab)Biosimilar Reference Antibody-GS40788

货号：GS40788

Vibostolimab is an investigational humanized monoclonal antibody that targets TIGIT (T-cell immunoreceptor with Ig and ITIM domains). It is primarily developed as a component of combination therapies for cancer, most notably in the fixed-dose combination MK-7684A (vibostolimab + pembrolizumab), aiming to enhance anti-tumor immune responses by simultaneously blocking both the PD-1 and TIGIT inhibitory pathways.